Yum China launches AI assistant for store managers, a groundbreaking advance in its tech-driven growth strategy

Yum China launches AI assistant for store managers, a groundbreaking advance in its tech-driven growth strategy

"Q-Smart" assistant will provide restaurant managers with broad-based support for day-to-day restaurant operations, allowing them to enhance their focus on delivering excellent customer service SHANGHAI, June 20, 2025 /PRNewswire/ -- Yum China...

111, Inc. Announces First Quarter 2025 Unaudited Financial Results

111, Inc. Announces First Quarter 2025 Unaudited Financial Results

Maintained Quarterly Operational Profitability Operating Expenses as a Percentage of Revenues Decreased 30 Basis Points YoY Maintained Quarterly Positive Operating Cash Flow SHANGHAI, June 19, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company")...

Japan Energy Summit & Exhibition Opens in Tokyo with Global Leaders Calling for Energy Resilience, Strategic Investment, and Long-Term Collaboration

Japan Energy Summit & Exhibition Opens in Tokyo with Global Leaders Calling for Energy Resilience, Strategic Investment, and Long-Term Collaboration

TOKYO, June 19, 2025 /PRNewswire/ -- The Japan Energy Summit & Exhibition, organised by dmg events, officially opened yesterday at Tokyo Big Sight, welcoming energy leaders, policymakers, and innovators from across the global energy value chain....

Paradigm Therapeutics, Inc. Announces an Additional Investment by Eshelman Ventures, LLC to Expedite Global Development and Global Registration of SD-101, A Topical Therapy for Treatment Across the Entire Skin Surface of All Subtypes of Epidermolysis Bull

Paradigm Therapeutics, Inc. Announces an Additional Investment by Eshelman Ventures, LLC to Expedite Global Development and Global Registration of SD-101, A Topical Therapy for Treatment Across the Entire Skin Surface of All Subtypes of Epidermolysis Bull

First Topical Therapy Developed to Treat the Wounds and Lesions on the Entire Skin Surface Across All EB Subtypes Funding to be Used to Accelerate Activities Associated with Increasing Manufacturing Development of SD-101 and Commercial Launch of the...

Newmark Expands Occupier Solutions into Singapore with Strategic Advisory Hires, Driving APAC Momentum as the Company Continues its Global Expansion

Newmark Expands Occupier Solutions into Singapore with Strategic Advisory Hires, Driving APAC Momentum as the Company Continues its Global Expansion

SINGAPORE, June 18, 2025 /PRNewswire/ -- Newmark Group, Inc. (Nasdaq: NMRK) ("Newmark" or "the Company"), a leading commercial real estate advisor and service provider to large institutional investors, global corporations, and other owners and...

International Pharmaceuticals, Inc. Partners with Anchanto to Power E-commerce Operations in the Philippines

International Pharmaceuticals, Inc. Partners with Anchanto to Power E-commerce Operations in the Philippines

CEBU CITY, Philippines, June 17, 2025 /PRNewswire/ -- Anchanto, the leading global B2B SaaS technology company in e-commerce and supply chain, announced its latest partnership with International Pharmaceuticals, Inc. (IPI), one of Philippines'...

Global Action to End Smoking Welcomes Nataliia Toropova as Chief Development Officer

Global Action to End Smoking Welcomes Nataliia Toropova as Chief Development Officer

Toropova brings decades of experience in international public health and tobacco harm reduction to Global Action's team of experts committed to funding work to end the smoking epidemic. NEW YORK, June 16, 2025 /PRNewswire/ -- Global Action to End...

Subgroup Analysis of Cadonilimab as First-Line Therapy for Advanced Cervical Cancer Reported in an Oral Presentation at ASCO 2025

Subgroup Analysis of Cadonilimab as First-Line Therapy for Advanced Cervical Cancer Reported in an Oral Presentation at ASCO 2025

HONG KONG, June 16, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") presented the subgroup analysis data from the Phase III COMPASSION-16 trial, evaluating cadonilimab, a first-in-class PD-1/CTLA-4 bispecific antibody, in the...

Sentient Digital, Inc. (SDi) Partners with Viasat to Support Korea Coast Guard Maritime Domain Awareness and Information Sharing Missions

Sentient Digital, Inc. (SDi) Partners with Viasat to Support Korea Coast Guard Maritime Domain Awareness and Information Sharing Missions

NEW ORLEANS, June 11, 2025 /PRNewswire/ -- Sentient Digital, Inc. (SDi), a leading provider of defense technology and engineering services, today announced our partnership with Viasat, a global leader in satellite communications, to deliver advanced...

Sanyou Biopharmaceuticals and Medicovestor, Inc. Forge Strategic Partnership to Develop First-in-Class Chemoimmunotherapy Antibody-Drug Conjugates

Sanyou Biopharmaceuticals and Medicovestor, Inc. Forge Strategic Partnership to Develop First-in-Class Chemoimmunotherapy Antibody-Drug Conjugates

SHANGHAI and NEW YORK, June 10, 2025 /PRNewswire/ -- Sanyou Biopharmaceuticals, a leading Shanghai-based high-tech biopharmaceutical company specializing in biologics R&D today announced the signing of a strategic cooperation agreement with...

  • 1
  • ...
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • ...
  • 42
  • menu
    menu